azulene has been researched along with hydrazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramenko, N; Antonyová, V; Brogyányi, T; Hosnedlová, B; Jakubek, M; Kaplánek, R; Kejík, Z; Martásek, P; Richardson, DR; Veselá, K; Vokurka, M | 1 |
1 other study(ies) available for azulene and hydrazine
| Article | Year |
|---|---|
Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
Topics: Azulenes; Cell Line, Tumor; Humans; Hydrazines; Hydrazones; Hydroxamic Acids; Iron; Iron Chelating Agents; Pancreatic Neoplasms; Receptors, Transferrin; Thiosemicarbazones | 2022 |